June 8, 2026
June 8, 2026
GSK pledges £44.5M in near term for UK biotech to explore cause of liver fibrosis regression
Share this post
Learn how we are unlocking unprecedented therapies for chronic diseases
Engitix London
4th Floor, The WestWorks,
195 Wood Lane, London, W12 7FQ,
United Kingdom
Registered Office
C/O Mercer & Hole Llp, 3 Lombard Street, London, United Kingdom, EC3V 9AA
